Home » FDA Seeks Input on Communicating Drug-Drug Interaction Information
FDA Seeks Input on Communicating Drug-Drug Interaction Information
As part of a continuing effort to address drug-drug interactions, the FDA’s Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will hold a meeting Sept. 25 to discuss strategies for the evaluation, interpretation and communication of drug-drug interaction information.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May